About Science Partnerships News Careers Contact Platform Overview Core Applications Partnership Highlights Drug Intelligent Science (DIS™) Transforming drug discovery and development through single-cell analytics We are transforming discovery and development by combining our Data Intelligence with our Single-Cell Science to achieve optimal outcomes for target discovery, drug candidate identification, lead optimization, and patient selection. Our DIS™ strategy overcomes several significant challenges of drug discovery and development, including: Patient heterogeneity Substantial scaling requirements Difficulty of identifying predictive biomarkers Core Applications DIS CelliGOTM Overview Our technology addresses a series of unmet needs and bottlenecks at the single-cell level through innovative solutions that allow broad immune cell profiling, functional screening, and deep sequence-based phenotypic characterization. We apply our droplet-based microfluidic technology with other cutting-edge single-cell methods for a variety of drug discovery and drug development applications. Partnership Highlights Previous Kite and HiFiBio Therapeutics Partner to Discover Novel Targets and Antibodies Against Acute Myeloid Leukemia Read More Research Collaboration to Develop Technology for the Treatment of Cancer Read More Research Collaboration to Develop Technology for the Treatment of Cancer Read More Next Partnerships Establishing strategic partnerships with leading pharmaceutical and biotechnology companies, as well as academic institutions. Learn more About Science Partnerships News Careers Contact © HiFiBiO Therapeutics, 2021. All Rights Reserved. Privacy Policy Manage cookie settings